Overall Neuropathy Limitations Scale (ONLS)
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- No Disability0–0
- Mild Disability1–3
- Moderate Disability4–6
- Severe Disability7–9
The Overall Neuropathy Limitations Scale (ONLS) calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include arms grade. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Quantifies the severity of functional disability in peripheral neuropathy by assessing upper and lower extremity functional activities. This validated scale is widely used to track disease progression and treatment response in various neuropathic conditions, particularly immune-mediated polyneuropathies.
Clinical Indication
The Overall Neuropathy Limitations Scale (ONLS) is indicated for bedside clinical practice to support Quantifies the severity of functional disability in peripheral neuropathy by assessing upper and lower extremity functional activities. This validated scale is widely used to track disease progression and treatment response in various neuropathic conditions, particularly immune-mediated polyneuropathies.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: Regular monitoring can help assess treatment response and disease progression.
ONLS Total Score = Arms Grade (0-5) + Legs Grade (0-7)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| arms_grade | integer | Yes | Arms functional disability grade based on ability to perform arm and hand functions |
| legs_grade | integer | Yes | Legs functional disability grade based on walking ability, climbing stairs, and running capacity |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | No Disability | No functional limitations |
| 1–3 | Mild Disability | Minimal functional limitations |
| 4–6 | Moderate Disability | Moderate functional limitations |
| 7–9 | Severe Disability | Significant functional limitations |
| 10–12 | Very Severe Disability | Profound functional limitations |
Evidence-Based References (EBM)
- Graham RC, Hughes RA. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry. 2006;77(8):973-6. doi: 10.1136/jnnp.2005.081547.DOI: 10.1136/jnnp.2005.081547
- Hughes RA, Donofrio P, Bril V, Dalakas MC, Deng C, Hanna K, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol. 2008;7(2):136-44. doi: 10.1016/S1474-4422(07)70329-0.DOI: 10.1016/S1474-4422(07)70329-0
- van Nes SI, Vanhoutte EK, van Doorn PA, Hermans M, Bakkers M, Kuitwaard K, et al. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology. 2011;76(4):337-45. doi: 10.1212/WNL.0b013e318208824b.DOI: 10.1212/WNL.0b013e318208824b